PHI with Hemorrhoid sclerotherapy
How does this condition affect your private health insurance?
Hämorrhoidensklerosierung is a common, minimally invasive treatment for internal hemorrhoids, primarily grades I and II. A sclerosant solution is injected near the hemorrhoid's base, causing the blood vessels to constrict and the tissue to scar and shrink. This reduces the size of the hemorrhoid, alleviating symptoms like bleeding, itching, and discomfort. The procedure is typically performed in an outpatient setting, requires no anesthesia, and has a quick recovery. While highly effective, especially for early-stage hemorrhoids, follow-up treatments may sometimes be necessary. It offers a less invasive alternative to surgery, improving quality of life for many sufferers by resolving symptomatic hemorrhoidal disease.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months (referring to hemorrhoid symptoms before treatment)
Duration of Illness (Lifetime)
Recurrent or chronic (referring to hemorrhoids), but treatable with good long-term outcomes for many
Cost of Treatment (Initial)
Typically covered by health insurance in many systems; otherwise, a few hundred euros/dollars per session.
Cost of Treatment (Lifetime)
Potentially higher if multiple sessions or recurrences are needed, but generally moderate compared to surgery.
Mortality Rate
Extremely low, practically negligible for this procedure.
Risk of Secondary Damages
Low: mild pain, discomfort, minor bleeding, or temporary urge to defecate. Very rarely, localized infection or prostate inflammation in men.
Probability of Full Recovery
High (70-90% success rate for appropriate grades I-II hemorrhoids), though recurrence is possible and may require re-treatment.
Underlying Disease Risk
High probability of associated factors: chronic constipation, straining during bowel movements, prolonged sitting, pregnancy, obesity, or a low-fiber diet.